Cargando…

Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption

BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Lingman, Ye, Xinyue, Sun, Pengbo, Xu, Pengfei, Wang, Liping, Liu, Zixiang, Huang, Xiaowei, Bai, Zhaoshi, Zhou, Changlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218270/
https://www.ncbi.nlm.nih.gov/pubmed/32403086
http://dx.doi.org/10.1016/j.ebiom.2020.102775
_version_ 1783532765090676736
author Ma, Lingman
Ye, Xinyue
Sun, Pengbo
Xu, Pengfei
Wang, Liping
Liu, Zixiang
Huang, Xiaowei
Bai, Zhaoshi
Zhou, Changlin
author_facet Ma, Lingman
Ye, Xinyue
Sun, Pengbo
Xu, Pengfei
Wang, Liping
Liu, Zixiang
Huang, Xiaowei
Bai, Zhaoshi
Zhou, Changlin
author_sort Ma, Lingman
collection PubMed
description BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino acids (AA) in the longer chain of EeCentrocin 1 (from the edible sea-urchin Echinus esculentus) were truncated and underwent further modification. To produce lead peptides with low toxicity and high efficacy, the antimicrobial activity or cytotoxicity of peptides was evaluated against various multidrug-resistant bacteria/fungi or mammalian cells in vivo/ in vitro. In addition, the stability and modes of action of the lead peptide were investigated. FINDINGS: EC1-17KV displayed potent activity and an expanded antimicrobial spectrum, especially against drug-resistant gram-negative bacteria and fungi, attributable to its enhanced amphiphilicity and net charge. In addition, it exhibits bactericidal/fungicidal activity and effectively increased the animal survival rate and mitigated the histopathological damage induced by multidrug-resistant P. aeruginosa or C. albicans in infected mice or G. mellonella. Moreover, EC1-17KV had a poor ability to induce resistance in bacteria and fungi and exhibited desirable high-salt/high-temperature tolerance properties. In bacteria, EC1-17KV promoted divalent cation release to damage bacterial membrane integrity. In fungi, it changed C. albicans membrane fluidity to increase membrane permeabilization or reduced hyphal formation to suppress biofilm formation. INTERPRETATION: EC1-17KV is a promising lead peptide for the development of antimicrobial agents against antibiotic resistant bacteria and fungi. FUNDING: This work was funded by the National Natural Science Foundation of China (No. 81673483, 81803591); National Science and Technology Major Project Foundation of China (2019ZX09721001-004-005); National Key Research and Development Program of China (2018YFA0902000); "Double First-Class" University project (CPU2018GF/GY16); Natural Science Foundation of Jiangsu Province of China (No. BK20180563); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
format Online
Article
Text
id pubmed-7218270
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72182702020-05-15 Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption Ma, Lingman Ye, Xinyue Sun, Pengbo Xu, Pengfei Wang, Liping Liu, Zixiang Huang, Xiaowei Bai, Zhaoshi Zhou, Changlin EBioMedicine Research paper BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino acids (AA) in the longer chain of EeCentrocin 1 (from the edible sea-urchin Echinus esculentus) were truncated and underwent further modification. To produce lead peptides with low toxicity and high efficacy, the antimicrobial activity or cytotoxicity of peptides was evaluated against various multidrug-resistant bacteria/fungi or mammalian cells in vivo/ in vitro. In addition, the stability and modes of action of the lead peptide were investigated. FINDINGS: EC1-17KV displayed potent activity and an expanded antimicrobial spectrum, especially against drug-resistant gram-negative bacteria and fungi, attributable to its enhanced amphiphilicity and net charge. In addition, it exhibits bactericidal/fungicidal activity and effectively increased the animal survival rate and mitigated the histopathological damage induced by multidrug-resistant P. aeruginosa or C. albicans in infected mice or G. mellonella. Moreover, EC1-17KV had a poor ability to induce resistance in bacteria and fungi and exhibited desirable high-salt/high-temperature tolerance properties. In bacteria, EC1-17KV promoted divalent cation release to damage bacterial membrane integrity. In fungi, it changed C. albicans membrane fluidity to increase membrane permeabilization or reduced hyphal formation to suppress biofilm formation. INTERPRETATION: EC1-17KV is a promising lead peptide for the development of antimicrobial agents against antibiotic resistant bacteria and fungi. FUNDING: This work was funded by the National Natural Science Foundation of China (No. 81673483, 81803591); National Science and Technology Major Project Foundation of China (2019ZX09721001-004-005); National Key Research and Development Program of China (2018YFA0902000); "Double First-Class" University project (CPU2018GF/GY16); Natural Science Foundation of Jiangsu Province of China (No. BK20180563); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Elsevier 2020-05-11 /pmc/articles/PMC7218270/ /pubmed/32403086 http://dx.doi.org/10.1016/j.ebiom.2020.102775 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research paper
Ma, Lingman
Ye, Xinyue
Sun, Pengbo
Xu, Pengfei
Wang, Liping
Liu, Zixiang
Huang, Xiaowei
Bai, Zhaoshi
Zhou, Changlin
Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title_full Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title_fullStr Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title_full_unstemmed Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title_short Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
title_sort antimicrobial and antibiofilm activity of the eecentrocin 1 derived peptide ec1-17kv via membrane disruption
topic Research paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218270/
https://www.ncbi.nlm.nih.gov/pubmed/32403086
http://dx.doi.org/10.1016/j.ebiom.2020.102775
work_keys_str_mv AT malingman antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT yexinyue antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT sunpengbo antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT xupengfei antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT wangliping antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT liuzixiang antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT huangxiaowei antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT baizhaoshi antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption
AT zhouchanglin antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption